I sold around half my shares yesterday at 25c. Very tempted to buy them back today at 19c.
The announcement was certainly a setback but we're not dead in the water. Modifications can be made to the trial to encourage/allow more participants. There should be no need to restart them from scratch.
Whist semaglutide may be a useful appetite suppressant it isn't a miracle cure for obesity and I'm sure we'll still have a market large enough to justify a share price many multiples of where we are now.
Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-136
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
